» Articles » PMID: 24737842

MYC and the Art of MicroRNA Maintenance

Overview
Specialty General Medicine
Date 2014 Apr 17
PMID 24737842
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

MYC is a noncanonical transcription factor that binds to thousands of genomic loci and affects >15% of the human transcriptome, with surprisingly little overlap between MYC-bound and -regulated genes. This discordance raises the question whether MYC chooses its targets based on their individual biological effects ("a la carte") or by virtue of belonging to a certain group of genes (on a "prix fixe" basis). This review presents evidence for a prix fixe, posttranscriptional model whereby MYC initially deregulates a select number of microRNAs. These microRNAs then target a broad spectrum of genes based solely on the presence in their 3' UTRs (untranslated regions) of distinct "seed" sequences. Existing evidence suggests that there are significant microRNA components to all key MYC-driven phenotypes, including cell-cycle progression, apoptosis, metabolism, angiogenesis, metastasis, stemness, and hematopoiesis. Furthermore, each of these cell-intrinsic and -extrinsic phenotypes is likely attributable to deregulation of multiple microRNA targets acting in different, yet frequently overlapping, pathways. The habitual targeting of multiple genes within the same pathway might account for the robustness and persistence of MYC-induced phenotypes.

Citing Articles

Molecular heterogeneity and MYC dysregulation in triple-negative breast cancer: genomic advances and therapeutic implications.

Priya , Kumar A, Kumar D 3 Biotech. 2025; 15(1):33.

PMID: 39777154 PMC: 11700964. DOI: 10.1007/s13205-024-04195-0.


The Genetic and Epigenetic Toxicity of Silica Nanoparticles: An Updated Review.

Zheng M, Chen Z, Xie J, Yang Q, Mo M, Liu J Int J Nanomedicine. 2024; 19:13901-13923.

PMID: 39735322 PMC: 11681786. DOI: 10.2147/IJN.S486858.


Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer.

Mollanoori H, Ghelmani Y, Hassani B, Dehghani M Sci Rep. 2024; 14(1):91.

PMID: 38167453 PMC: 10761719. DOI: 10.1038/s41598-023-50230-0.


EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma.

Akyuz N, Janjetovic S, Ghandili S, Bokemeyer C, Dierlamm J Viruses. 2023; 15(9).

PMID: 37766215 PMC: 10537407. DOI: 10.3390/v15091808.


Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration.

Illi B, Nasi S Pathophysiology. 2023; 30(3):346-365.

PMID: 37606389 PMC: 10443299. DOI: 10.3390/pathophysiology30030027.


References
1.
Chang T, Yu D, Lee Y, Wentzel E, Arking D, West K . Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2007; 40(1):43-50. PMC: 2628762. DOI: 10.1038/ng.2007.30. View

2.
Baumjohann D, Kageyama R, Clingan J, Morar M, Patel S, de Kouchkovsky D . The microRNA cluster miR-17∼92 promotes TFH cell differentiation and represses subset-inappropriate gene expression. Nat Immunol. 2013; 14(8):840-8. PMC: 3720769. DOI: 10.1038/ni.2642. View

3.
Dang C, Le A, Gao P . MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009; 15(21):6479-83. PMC: 2783410. DOI: 10.1158/1078-0432.CCR-09-0889. View

4.
Hong L, Lai M, Chen M, Xie C, Liao R, Kang Y . The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res. 2010; 70(21):8547-57. PMC: 2970743. DOI: 10.1158/0008-5472.CAN-10-1938. View

5.
Landay M, Oster S, Khosravi F, Grove L, Yin X, Sedivy J . Promotion of growth and apoptosis in c-myc nullizygous fibroblasts by other members of the myc oncoprotein family. Cell Death Differ. 2000; 7(8):697-705. DOI: 10.1038/sj.cdd.4400701. View